Quarterly report pursuant to Section 13 or 15(d)

Equity Offerings (Details)

v3.22.1
Equity Offerings (Details) - USD ($)
3 Months Ended
Dec. 06, 2021
Mar. 31, 2022
Mar. 31, 2021
Net proceeds from the sale of common shares   $ 15,547,815 $ 1,542,465
Common stock issued under prospectus supplement dated April 9, 2021      
Number of shares issued during the period   2,730,725  
Common stock issued under prospectus supplement dated December 6, 2021      
Net proceeds from the sale of common shares   $ 15,547,815  
Common stock shares available for sale   22,118,520  
ATM      
Number of shares issued during the period     303,407
Net proceeds from the sale of common shares     $ 1,542,465
ATM | Common stock issued under prospectus supplement dated December 6, 2021      
Authorized amount to be issued $ 44,925,000